- This research study suggests that health care costs associated with radiation treatment for early-stage breast cancer could be reduced if patients received the least expensive radiation regimen for which they were safely eligible.
- However, this was a retrospective study, meaning the authors did not collect their own data.
- Ultimately, the biggest limitation of this study is the researchers do not know the reasons behind the choice of radiation treatment for each patient.
- Young breast cancer survivors should work with their healthcare providers to determine what the best treatment is for them.
- It is difficult to determine an individual’s out-of-pocket savings for those who are eligible for the shorter course of radiation therapy due to variation between providers/hospitals, health care plans, and other factors.